The Global Health Body Sounds Warning Over Critical Lack of Weight-Loss Medications
Less than one in 10 people eligible to benefit from obesity jabs like Wegovy have access to them, states the global health agency as it releases its first advice on the therapies.
Considering over a billion people worldwide currently obese, it is advocating for broader and more equitable access to this class of drugs.
According to projections, in excess of 2,000,000,000 are projected to be living with obesity by 2030 if no action is taken.
"Our new guidance affirms that excess weight is a lifelong illness that can be treated with holistic and ongoing support," stated the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and logistical bottlenecks are significant obstacles to universal availability to the injections that can help people shift substantial body mass, explains the organization.
Skinny Jab Shortage
Despite the present best projected outlook, the supply of these medications would only suffice for approximately 100 million people – under 10% of those who need them, according to the health organization.
The guideline encourages countries and companies to increase availability, by strategies including licensing agreements.
A patent on a key compound – the primary component of a leading brand – is scheduled to end in several nations in 2026.
How Obesity Drugs Operate
These medications mimick a natural hormone to reduce digestion speed, reduce hunger and boost feelings of fullness so users eat less.
Individuals commonly start to lose weight after several weeks of beginning the regular doses.
Studies indicates patients may see weight return a year later of stopping the treatment, when their usual food cravings return.
Being above a healthy weight increases your risk for developing diseases, including type 2 diabetes, cardiovascular issues, stroke, and some malignancies.
Obesity impacts individuals in countries worldwide and was linked to millions of fatalities worldwide in 2024, as per the health agency.